首页> 美国卫生研究院文献>American Journal of Physiology - Cell Physiology >Cellular Mechanisms of Tissue Fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis
【2h】

Cellular Mechanisms of Tissue Fibrosis. 4. Structural and functional consequences of skeletal muscle fibrosis

机译:组织纤维化的细胞机制。 4.骨骼肌纤维化的结构和功能后果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Skeletal muscle fibrosis can be a devastating clinical problem that arises from many causes, including primary skeletal muscle tissue diseases, as seen in the muscular dystrophies, or it can be secondary to events that include trauma to muscle or brain injury. The cellular source of activated fibroblasts (myofibroblasts) may include resident fibroblasts, adult muscle stem cells, or inflammatory or perivascular cells, depending on the model studied. Even though it is likely that there is no single source for all myofibroblasts, a common mechanism for the production of fibrosis is via the transforming growth factor-β/phosphorylated Smad3 pathway. This pathway and its downstream targets thus provide loci for antifibrotic therapies, as do methods for blocking the transdifferentiation of progenitors into activated fibroblasts. A structural model for the extracellular collagen network of skeletal muscle is needed so that measurements of collagen content, morphology, and gene expression can be related to mechanical properties. Approaches used to study fibrosis in tissues, such as lung, kidney, and liver, need to be applied to studies of skeletal muscle to identify ways to prevent or even cure the devastating maladies of skeletal muscle.
机译:骨骼肌纤维化可能是由多种原因引起的毁灭性临床问题,包括原发性骨骼肌组织疾病(如在肌肉营养不良症中所见),或者它可以继发于肌肉或脑部受伤等事件。激活的成纤维细胞(成肌纤维细胞)的细胞来源可能包括驻留的成纤维细胞,成年肌肉干细胞或炎性或血管周细胞,具体取决于所研究的模型。即使可能没有所有肌成纤维细胞的单一来源,但产生纤维化的常见机制是通过转化生长因子-β/磷酸化的Smad3途径。因此,该途径及其下游靶标为抗纤维化治疗提供了场所,而阻断祖细胞转分化为活化的成纤维细胞的方法也是如此。需要用于骨骼肌的细胞外胶原网络的结构模型,以便胶原含量,形态和基因表达的测量可以与机械性能相关。用于研究组织(例​​如肺,肾和肝)纤维化的方法需要应用于骨骼肌的研究,以确定预防或什至治愈破坏性骨骼肌疾病的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号